Goflikicept for pericarditis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Dec 2020: Trial started, NCT05673902
  2. 6 Jan 2023: Trial registered, NCT05673902

The trials

NCT05673902: Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis

State
Under way
Phase
Phase 3
People
17 taking part
Started
11 Dec 2020
Primary completion
Jan 2026
Arms
RPH-104 80 mg
Results
None posted
  1. 11 Dec 2020: Trial started
  2. 6 Jan 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.